CNTX · Context Therapeutics Inc. · Debt
$0.24
+0.00 (+0.46%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$21.90M
Shares
91.88M
Volume · Oct 20
532.7K
Avg daily vol (3M)
1.56M
Debt Profile
Processing began with filings dated Mar 23, 2026 · latest terminal result Mar 23, 2026Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Operating lease liabilities | 2026-06-30 | USD 200,000 | 10-Q filed 2026-08-05 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1842952
CUSIP
21077P108
13F (30d)
10 filings
10 filers
Visit website
Investor relations